Related references
Note: Only part of the references are listed.Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction
Sunao Kojima et al.
ATHEROSCLEROSIS (2007)
Reduced adiponectin level is associated with severity of coronary artery disease
Kazuo Hara et al.
INTERNATIONAL HEART JOURNAL (2007)
The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients
Roberto Negro et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2006)
The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension
Sanae Watanabe et al.
CLINICAL THERAPEUTICS (2006)
The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin-resistant subjects
Jutta M. Nagel et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Takashi Kadowaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice
Kana Araki et al.
HYPERTENSION (2006)
Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways
N Kubota et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b
Trevor G. Marshall et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2006)
Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study
T Isobe et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
PPAR γ-activating angiotensin type-1 receptor blockers induce adiponectin
R Clasen et al.
HYPERTENSION (2005)
Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes
AM Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Ageing and plasma adiponectin concentration in apparently healthy males and females
M Adamczak et al.
CLINICAL ENDOCRINOLOGY (2005)
Adiponectin and the development of type 2 diabetes - The atherosclerosis risk in communities study
BB Duncan et al.
DIABETES (2004)
Old antihypertensives and new diabetes
LH Opie et al.
JOURNAL OF HYPERTENSION (2004)
Peroxisome proliferator-activated receptor γ (PPAR-γ) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria
MI Yilmaz et al.
ENDOCRINE (2004)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
S Julius et al.
LANCET (2004)
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
SC Benson et al.
HYPERTENSION (2004)
Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus
T Yatagai et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population - The Funagata study
M Daimon et al.
DIABETES CARE (2003)
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
M Cnop et al.
DIABETOLOGIA (2003)
Association of hypoadiponectinemia with coronary artery disease in men
M Kumada et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Decreased plasma adiponectin concentration in patients with essential hypertension
M Adamczak et al.
AMERICAN JOURNAL OF HYPERTENSION (2003)
Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians
C Snehalatha et al.
DIABETES CARE (2003)
Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein
H Nishizawa et al.
DIABETES (2002)
Disruption of adiponectin causes insulin resistance and neointimal formation.
N Kubota et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway
N Ouchi et al.
CIRCULATION (2000)
An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls
Y Okamoto et al.
HORMONE AND METABOLIC RESEARCH (2000)
Share Paper
